Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124677 | SCV000168111 | benign | not specified | 2011-09-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000124677 | SCV000315370 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000124677 | SCV000340761 | benign | not specified | 2016-05-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000677030 | SCV000603302 | benign | not provided | 2023-10-26 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001139590 | SCV001299764 | likely benign | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type) | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV000677030 | SCV001724913 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000677030 | SCV002544052 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | DGUOK: BS1, BS2 |
Fulgent Genetics, |
RCV002498597 | SCV002812563 | likely benign | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type); Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4; Portal hypertension, noncirrhotic, 1 | 2022-02-22 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000239473 | SCV000297865 | pathogenic | Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 | 2016-08-18 | no assertion criteria provided | literature only | |
Mayo Clinic Laboratories, |
RCV000677030 | SCV000802864 | uncertain significance | not provided | 2016-02-23 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000124677 | SCV001741401 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000677030 | SCV001920619 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000677030 | SCV001926905 | likely benign | not provided | no assertion criteria provided | clinical testing |